Latest News for BGMS
Calliditas Therapeutics AB (publ) (NASDAQ: CALT - Get Free Report) and Cyclacel Pharmaceuticals (NASDAQ: BGMS - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation. Insider and Institutional Ownership 2.8%
Cyclacel Pharmaceuticals (NASDAQ: BGMS - Get Free Report) and Achaogen (OTCMKTS:AKAOQ - Get Free Report) are both small-cap manufacturing companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership. Institutional and Insider Ownership 23.6% of Cyclacel…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BGMS.
U.S. House Trading
No House trades found for BGMS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.